TRPV1 and arthritic joint disease: Consistent with a decrease in arthritis scores, pannus, bone destruction, and cartilage damage were significantly reduced in TRPV1-/- mice at 4, 8, 12 weeks (Fig. 4G–J); was not reduced in TRPV1+/- mice at 4 weeks (suppl Fig. 1).